Drugs-health.com is your healthy decision. You health is our speciality.

Cipro use can lead to super-anthrax

Jul.26, 2010

The massive use of antibiotics against anthrax can lead to emergence of super-virus, a strain of anthrax that is resistant to treatment with currently known remedies.

The U.S. government, in order to prevent an epidemic of anthrax, purchased in large quantities antibiotic Cipro (ciprofloxacin). Tens of thousands of U.S. citizens take this medicine as a preventive treatment. However, unjustified administration of powerful antibiotics develops “immunity” in many pathogenic viruses, and the same could happen with anthrax. In addition, under such conditions increases the likelihood of the possibility of purposeful development of a form of anthrax resistant to medicines that threatens a catastrophe.

Levaquin :more therapeutic indications

Jul.26, 2010

Currently in clinical practice are becoming more common so-called respiratory fluoroquinolones, which on one hand, preserve the activity of the early fluoroquinolones (eg ciprofloxacin) against gram-negative organisms, but on the other – are more active against pneumococci and atypical bacteria.

Levofloxacin, the active component of Levaquin, is the most studied substance among respiratory fluoroquinolones. It has been prescribed to more than 300 million patients worldwide. A number of clinical studies has confirmed Levaquin’s high efficacy and safety both in the traditional indications for this group of antibiotics, such as acute sinusitis, exacerbation of chronic bronchitis, community-acquired pneumonia, urinary tract infections, and in some other diseases: nosocomial pneumonia, chronic bacterial prostatitis.

Staxyn. Staxyn has been approved by FDA. Staxyn Vardenafil

Jun.23, 2010

United states Food and Drugs Administration approved the medication Staxyn (varbenafil HCL) tablets for the treatment of erectile dysfunction. The main advantage of Staxyn is that tablets are quickly dissolved in the mouth cavity under the tongue. Staxyn is made by GlaxoSmithKline and Merck & Co. The medication will be very soon available on US pharmaceutical market.

Jalyn. FDA approved the drug Jalyn made by Glaxo Smith Klein.

Jun.22, 2010

On June 14, 2010 Food and Drug Administration USA (FDA) approved drug Jalyn (dutasteride 0.5 mg and tamsulosin 0.4 mg) for the treatment of benign prostatic hyperplasia (BPH) in men with prostate enlargement.
Dutasteride is an inhibitor of 5α-reductase, tamsulosin is α1-adrenoceptor blocker. The combination

of dutasteride and tamsulosin has been properly studied in patients with BPH and it was shown high effectiveness and safety profile.

Green tea may slow the progression of chronic lymphocytic leukemia

Jun.17, 2010

The substance contained in green tea may become another tool for the treatment of patients with chronic lymphocytic leukemia (CLL). Researchers from the Mayo Clinic conduct the second phase of study of substance called epigallocatechin gallate (EGCG), also known as Epigallocatechin 3-gallate.

Prolia (denosumab). Prolia has been approved by FDA

Jun.14, 2010

US Food and Drug Administration approved the drug Prolia (denosumab) for the treatment of osteoporosis in postmenopausal women at high risk of fractures as well as for the treatment of bone tissue loss in men, prostate cancer patients with similar risk.

Clinical studies have shown that Denosumab works by improving bone mineral density and reducing different types of fractures.

Zymaxid. Bacterial conjunctivitis treatment with Zymaxid

May.24, 2010

FDA approved Zymaxid ophthalmic solution for the treatment of bacterial conjunctivitis. Zymaxid contains the active ingredient gatifloxacin that belongs to a group of fluoroquinolone antibiotics. Like other fluoroquinolone antibiotics Gatifloxacin works by inhibiting the enzyme DNA-gyrase. This enzyme is necessary for repairing and synthesis of bacterial genetic material (DNA).

Natazia. Natazia – oral contraceptive. Birth control with Natazia

May.11, 2010

Natazia is a new oral contraceptive that has been recently approved by FDA. Natazia is made by the pharmaceutical company Bayer HealthCare Pharmaceuticals. Natazia is currently available in the European Union under the name Qlaira. Natazia is the first four-phase oral contraceptive that releases female sex hormone progestin at four times for twenty eight day in treatment cycle. Natazia contains 2 active active ingredients: estrogen (estradiol valerate) and progestin (dienogest).

Smoking during pregnancy can cause mental problems in children

May.08, 2010

According to a new study conducted in Finland, smoking during pregnancy can cause mental problems in the children.
It is well known that if a woman smokes during pregnancy, it can lead to a large amount of congenital diseases including respiratory diseases such as asthma, heart and blood vessels diseases, high risk of ENT infections and other health problems. The new study was focused on the relationship of mental health problems such as depression, attention deficit and hyperactivity disorder (ADHD) and maternal smoking during pregnancy.

Health benefits of Olive oil

May.08, 2010

According to a new study conducted in the UK regular use of olive oil high consumption can significantly reduce the risk of ulcerative colitis developing.
Ulcerative colitis is a chronic inflammatory disease of the rectum and colon. The main symptoms of the disease include abdominal pain, diarrhea and weight loss. The study found that people who regularly consume olive oil are at lower risk of ulcerative colitis development.